Page 8 of 28

2 Year Follow-Up

As part of the Baby-OSCAR Trial, parents will be contacted when their child(ren) reach(es) 2 years of age to complete a questionnaire about their child(ren)'s health and development. This will help us get a better picture of the study results.

Many trials will include an element of long-term follow-up; It is just as important to record the long-term effects as it is the immediate results following treatment.

By completing this long-term follow-up, the researchers can spot any long-term benefits to the treatments received, and also monitor any long-term negative outcomes. The conclusions of one such study demonstrate the importance of this follow-up stage in gaining the bigger picture for study results and how these follow-up developmental assessments can provide key information for future treatments and further trials.  The results have been published in the following paper: Neurodevelopmental Outcome at 2 Years of Age according to Patent Ductus Arteriosus Management in Very Preterm Infants; Bourgoin, L. et al (Neonatology, 2016). You can read more about it by clicking on the link below.

Recruitment gets underway!

After a year of manufacturing the new medication, the main trial has launched with Birmingham Women's Hospital kick starting the recruitment.  Dr Rasiah and the team are part of a bigger pool of researchers, participating in Baby-OSCAR, helping to fill these knowledge gaps in the best care for babies who have been born early (prematurely) with a large PDA.

Photo courtesy of hospital website:

Let the Main Trial Commence...

We are extremely pleased to announce that we are up and running for the main phase of the trial. Congratulations Birmingham Women's Hospital for being the first site to open for the main phase. We will keep you posted with further exciting news as more sites open and recruitment gets underway. Watch this space...

Document Boxes are on their way...

Packing the Document Boxes

We are getting there! 7 document boxes packed up and on their way to sites ready for launching the Main Trial.

These boxes contain all the documents needed to run the trial in what is hopefully a neat, tidy and organised way.


Page 8 of 28

Subscribe to this news feed

This study is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (Reference Number 11/92/15). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.